Abstract
Accurate assessment of renal function is critical for managing Chronic Kidney Disease (CKD). While the glomerular filtration rate (GFR) is the gold standard for evaluation, direct measurement is clinically cumbersome. Consequently, various estimation equations (eGFR) are used, though their accuracy varies across patient populations. This study developed a classification decision tree model to dynamically select the most suitable eGFR equation for individual patients. Using data from 518 CKD patients, the model selects between the BIS-2, CKD-EPI(CysC), CKD-EPI(Cr-CysC), and Ruijin equations based on clinical variables. The resulting model significantly outperformed 13 traditional equations, achieving a Mean Absolute Error (MAE) of 8.5 and a Root Mean Square Error (RMSE) of 12.2 in the test set.
The Challenge of GFR Estimation
The Glomerular Filtration Rate (GFR) represents the volume of fluid filtered from the renal glomerular capillaries into the Bowman's capsule per unit time. Direct measurement using exogenous markers like $^{99m}$Tc-DTPA (Gate’s method) is precise but invasive and expensive. Most clinicians rely on eGFR formulas based on endogenous markers like creatinine or cystatin C. However, the performance of these formulas is often inconsistent, influenced by factors such as age, body mass index (BMI), and underlying pathologies like diabetes.
Methodology: A "Meta-Model" Approach
Rather than deriving a new mathematical formula, researchers built a classification decision tree using the CART algorithm to act as a clinical "traffic controller." The model evaluates a patient's specific clinical profile to assign the most accurate existing equation.
The study analyzed 518 patients from the First Affiliated Hospital of Zhejiang Chinese Medicine University, divided into a training set (n=362) and a test set (n=156). Out of 28 initial clinical variables, the tree identified six key predictors:
- Diabetic Nephropathy (DN) status
- Body Surface Area (BSA)
- Body Mass Index (BMI)
- 24-hour urine protein quantity
- Age
- Use of RASi (Renin-Angiotensin System inhibitors)
Performance and Results
The decision tree model demonstrated a marked improvement in accuracy over traditional "one-size-fits-all" equations. In the validation phase, the model's predictions were compared against 13 standard formulas, including MDRD and various CKD-EPI iterations.
The model achieved the lowest error rates (MAE 8.5, RMSE 12.2). For comparison, the widely used MDRD equation showed significantly higher deviation. Bland–Altman analysis confirmed that the decision tree approach had the smallest degree of variation and the most centralized bias relative to the measured GFR (sGFR).
Clinical Implications
The primary advantage of this model is its interpretability. Unlike "black-box" neural networks, the decision tree allows clinicians to follow the logic of the selection process. For instance, the model prioritizes the BIS-2 equation for patients with diabetic nephropathy, while favoring cystatin C-based equations for patients with higher BMI/BSA, where creatinine-based measures are often less reliable due to muscle mass variations.
While the study is limited by its specific geographic cohort (mainland China), it proves that ensemble-style machine learning can effectively bridge the gap between complex direct measurements and simplified estimation formulas. Future work will focus on multi-center external validation to ensure global applicability.
Summary updated